Methods and compositions for delivery of biologics
US10883119B2 · kind B2 · utility
0Cited by
39References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 11, 2013 |
| Grant date | Jan 5, 2021 |
| Priority date | — |
| Expiry date | Aug 31, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y301/01008
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Nucleases and methods of using these nucleases for genetic alteration of red blood cells (RBCs), for example for providing for a protein lacking in a monogenic disorder or a biologic for the treatment of exposure to a toxin using genetically altered RBCs.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.